Trial Profile
Efficacy and Safety of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion in Uncontrolled Type 2 Diabetes
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Insulin lispro
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 27 Jun 2018 New trial record